18 results
F-1
SPRC
SciSparc Ltd.
27 Feb 24
Registration statement (foreign)
4:15pm
there is reasonable evidence of an association of a serious hazard with the drug.
The medications commonly used to treat symptoms of TS can be divided
424B4
n6ztq9ahdtqnd lj
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
g2gej 18cb3
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
oi455o ws
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
pa8x q3vho1zd584dl
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
n2qi1
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
424B5
yfw4 6fhd
5 Dec 19
Prospectus supplement for primary offering
5:29pm
424B5
pold6hy75b
1 Apr 19
Prospectus supplement for primary offering
6:57am
424B2
npmh1l4x9cfsnvduho
9 Aug 18
Prospectus for primary offering
11:19am
F-3/A
9z7er6e1wtflg6klr
17 Jul 18
Shelf registration (foreign) (amended)
1:29pm
F-3
d6t lssn48tsjlm3y
20 Jun 18
Shelf registration (foreign)
2:38pm
20-F
isqvfx3sqzg
1 May 17
Annual report (foreign)
12:00am
- Prev
- 1
- Next